We are live on ! Find out more
RGEN icon

Repligen

141.01 USD
-2.59
1.8%
At close Updated Jul 31, 4:00 PM EDT
Pre-market
After hours
141.89
+0.88
0.62%
1 day
-1.8%
5 days
6.93%
1 month
3.35%
3 months
19.19%
6 months
-6.69%
Year to date
-14.2%
1 year
20.45%
5 years
-43.11%
10 years
372.08%
 

About: Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category (about 55% of total revenue), while chromatography, proteins, and process analytics are 21%, 11%, and 13%, respectively. Customers in North America, Europe, and Asia-Pacific contribute about 44%, 37%, and 19% of revenue, respectively.

Employees: 2,000

0
Funds holding %
of 8,134 funds
0
Positive news %
of 15 articles
Price charts implemented using Lightweight Charts™